Sun Pharmaceutical’s SPARC Unit Hopes To Kindle India Research Pipeline
This article was originally published in PharmAsia News
Executive Summary
Sun Pharma’s research unit SPARC shared an update of its research pipeline, but analysts are short on excitement, owing mostly to delays on timelines.